Focus Partners Wealth
TECH icon

Focus Partners Wealth’s Bio-Techne TECH Stock Holding History

Focus Partners Wealth’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,366
Closed -$1.49M – 2828
2025
Q4 		$1.49M Buy
25,366
+18,858
+290% +$1.15M ﹤0.01% 1455
2025
Q3 		$340K Buy
+6,508
New +$349K ﹤0.01% 1787

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Focus Partners Wealth's TECH Position: Q1 2026 in Review

Focus Partners Wealth sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 25,366 shares — an estimated $1.49M sold.

Focus Partners Wealth first reported a position in TECH in Q3 2025 and held it in 2 quarters. The position peaked at $1.49M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Focus Partners Wealth reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 25,366 Bio-Techne shares in Q1 2026, an estimated $1.49M.
  • Focus Partners Wealth first reported a position in Bio-Techne in Q3 2025 and held it in 2 quarters.
  • Focus Partners Wealth's Bio-Techne position peaked at $1.49M in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.